Korean J healthc assoc Infect Control Prev.  2023 Dec;28(2):183-184. 10.14192/kjicp.2023.28.2.183.

The Practicability of Carbapenem-resistant Enterobacterales Surveillance Culture

• Kim YA

• KMID: 2549944
• DOI: http://doi.org/10.14192/kjicp.2023.28.2.183

Reference

1. Thatrimontrichai A, Apisarnthanarak A. 2020; Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: what should be considered? J Formos Med Assoc. 119:1581–5. DOI: 10.1016/j.jfma.2019.08.015. PMID: 31471223.

2. Jeong H, Hyun J, Lee Y. 2022; Characteristics of carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Wkly Rep. 15:2354–63.

3. Lee KH. 2023; The value and clinical application of carbapenem-resistant Enterobacterales surveillance culture. Korean J healthc assoc Infect Control Prev. 28:185–191. DOI: 10.14192/kjicp.2023.28.2.185.

4. Korea Center for Disease Control & Prevention. Guidelines for control of patients with carbapenemase producing carbapenem-resistant Enterobacteriaceae. https://www.koshic.org/related/카바페넴내성장내세균속지침.pdf. (Updated on 15 March 2012).

5. Kim N, Hong KH, Park JS, Roh KH, Shin S. 2023; Laboratory diagnosis of carbapenemase-producing Enterobacterales. Korean J Healthc Assoc Infect Control Prev. 28:42–9. DOI: 10.14192/kjicp.2023.28.1.42.

6. Huang YT, Kuo YW, Lee NY, Tien N, Liao CH, Teng LJ, et al. 2022; Evaluating NG-test CARBA 5 multiplex immunochromatographic and Cepheid Xpert Carba-R assays among carbapenem-resistant Enterobacterales isolates associated with bloodstream infection. Microbiol Spectr. 10:e0172821. DOI: 10.1128/spectrum.01728-21. PMID: 35019772. PMCID: PMC8754146.